Robbie Rogart is a counsel in the Mass Tort, Product, and Consumer Litigation, Product Risk Management, and Litigation groups in Crowell & Moring's Washington, D.C. office. Robbie represents clients across numerous industries in a diverse array of commercial, class action, multi-district, health care, and products liability litigations in state and federal courts. Robbie also provides counseling regarding product liability, risk management, and consumer product regulatory compliance, with a focus on health care and medical devices.
RECENT EXPERIENCE
- Defending an international medical device manufacturer in all U.S. product liability litigation.
- Defending a health care services and products company in U.S. product liability litigation related to medical devices.
- Defending an international medical device manufacturer in product liability litigation in the United States, including issues related to the Federal Food, Drug and Cosmetic Act and the Premarket Approval (PMA) process.
- Defending Blue Cross and Blue Shield companies in Multidistrict Litigation (MDL) national and statewide class actions asserting antitrust claims.
- Defended an insurance risk retention group in settlement of numerous class action lawsuits.
- Negotiated and supported “limited fund” settlement of hundreds of class action lawsuits against a university following its loss of accreditation.
- Defended a major retailer against a potential civil penalty enforcement action for alleged late reporting regarding a product recall.
- Defended a product manufacturer in MDL national class actions asserting claims under the Telephone Consumer Protection Act.
In addition, Robbie has an active pro bono practice, including recent work on a child custody case, a special education matter in D.C. Public Schools, defense of a public housing tenant in an eviction proceeding by D.C.H.A. for nonpayment of rent, and research regarding potential Fourth Amendment implications of searches in the homes of public housing tenants.
Robbie graduated with high honors from the University of Virginia in 2009 with a B.A. in political philosophy, policy & law. She earned her J.D. from the University of Virginia School of Law in 2012. During law school, Robbie interned for the Honorable Marian Blank Horn on the U.S. Court of Federal Claims and served as an articles editor on the Journal of Law & Politics. Before joining Crowell & Moring, Robbie clerked for the Honorable John F. Anderson on the U.S. District Court for the Eastern District of Virginia in Alexandria, Virginia.
Affiliations
Admitted to practice: District of Columbia, Virginia
Publications
-
"FDA Issues First-of-Its-Kind Guidance for Manufacturers of 3D-Printed Medical Devices," Crowell & Moring's Recent Happenings in Advertising & Product Risk Management – December 2017
(December 20, 2017).
Authors: Rebecca Baden Chaney, Robbie Rogart, and Chalana Netasha Damron.
-
"A New Twist on a Familiar Theme: NJ Lawsuit Targets Retailer’s Savings Claims, Seeking Damages Under Once Obscure Statute," Crowell & Moring's Retail & Consumer Products Law Observer
(March 23, 2017).
Authors: Robbie Rogart and Lauren B. Aronson.
-
"Update: Class Action Reform Bill Passes House 220-201," Crowell & Moring's Retail & Consumer Products Law Observer
(March 17, 2017).
Authors: Scott L. Winkelman, Rebecca Baden Chaney and Robbie Rogart.
Client Alerts & Newsletters
-
"10 Ways to Reduce Cyberattack Risks on Internet-Connected Medical Devices,"
Mass Tort, Product, and Consumer Litigation Alert
(September 24, 2021).
Contacts: Andrew D. Kaplan, Robbie Rogart Jost, Mimi S. Dennis
-
"Proposed Legislation Would Expand FDA Authority Over Counterfeit Medical Devices,"
Mass Tort, Product, and Consumer Litigation Alert
(October 2, 2020).
Contacts: Andrew D. Kaplan, Hilary Johnson, Robbie Rogart Jost
-
"Supreme Court Decision Raises New Questions on Impossibility Preemption in Cases Challenging Sufficiency of Drug Label Warnings,"
Mass Tort, Product, and Consumer Litigation Alert
(June 7, 2019).
Contacts: John Fuson, Andrew D. Kaplan, Robbie Rogart Jost
-
"Recent Happenings in Advertising & Product Risk Management – December 2017,"
Advertising & State AG Alert
(December 20, 2017).
Contacts: Christopher A. Cole, Cheryl A. Falvey, John Fuson, David Ervin, Lauren Aronson, Matthew Cohen, Rebecca Baden Chaney, Robbie Rogart Jost, Kate M. Watkins, Rukiya Mohamed
-
"The U.S. House Sets Out To Reform Class and Mass Actions,"
(March 16, 2017).
Contacts: Rebecca Baden Chaney, Robbie Rogart Jost, Scott L. Winkelman
-
"Court Denies Michaels’ Motion to Dismiss CPSC Penalty Enforcement Action and Finds that Failure to Report is a Continuing Violation,"
Advertising & State AG Alert
(April 4, 2016).
Contact: Robbie Rogart Jost
-
"Supreme Court Limits Effect of Rule 68 for Class Actions in Campbell-Ewald,"
Advertising & State AG Alert
(January 29, 2016).
Contact: Robbie Rogart Jost
-
"FDA Loses Battle to Limit Truthful, Non-Misleading Off-Label Promotion of Approved Drugs,"
Advertising & State AG Alert
(August 2015).
Contacts: Andrew D. Kaplan, Robbie Rogart Jost
-
""Natural" Food Labeling Decision Delivers Defense-friendly Clarity,"
Advertising & State AG Alert
(December 19, 2014).
Contacts: John Fuson, Robbie Rogart Jost
-
"Virginia Court Confirms Standard for Revealing Identities of Anonymous Online Defamers,"
Advertising & State AG Alert
(March 10, 2014).
Contacts: Clifford J. Zatz, Robbie Rogart Jost
Press Coverage
Firm News & Announcements